Growth Metrics

Fulgent Genetics (FLGT) Receivables - Other (2016 - 2025)

Fulgent Genetics' Receivables - Other history spans 10 years, with the latest figure at $1.1 million for Q4 2025.

  • On a quarterly basis, Receivables - Other fell 35.86% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 35.86% decrease, with the full-year FY2025 number at $1.1 million, down 35.86% from a year prior.
  • Receivables - Other hit $1.1 million in Q4 2025 for Fulgent Genetics, down from $1.4 million in the prior quarter.
  • Over the last five years, Receivables - Other for FLGT hit a ceiling of $19.8 million in Q4 2022 and a floor of $66000.0 in Q1 2023.
  • Historically, Receivables - Other has averaged $2.2 million across 5 years, with a median of $1.2 million in 2024.
  • Biggest five-year swings in Receivables - Other: soared 1702.27% in 2021 and later tumbled 93.35% in 2023.
  • Tracing FLGT's Receivables - Other over 5 years: stood at $1.4 million in 2021, then soared by 1313.83% to $19.8 million in 2022, then tumbled by 93.35% to $1.3 million in 2023, then skyrocketed by 34.04% to $1.8 million in 2024, then plummeted by 35.86% to $1.1 million in 2025.
  • Business Quant data shows Receivables - Other for FLGT at $1.1 million in Q4 2025, $1.4 million in Q3 2025, and $2.1 million in Q2 2025.